Clinical Trial Update: An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis [Phase 2]

View source ↗

Summary

Phase 2 open-label study evaluating BOR15001L7 for safety and efficacy in recurrent herpes labialis (cold sores).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis

Drugs mentioned

• BOR15001L7

Snippet

Sponsor: Laboratoire Boreaderme Inc. | Conditions: Recurrent Herpes Labialis | Phase 2 | Status: UNKNOWN